Donepezil ameliorates gut barrier disruption in doxorubicin-treated rats
Food and Chemical Toxicology · 2024
DOI: 10.1016/j.fct.2024.114741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2024. Verfasst von Kanokphong Suparan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand; Neurophysiology Unit, Cardiac E…. Hauptthemen laut MEDLINE: Donepezil, Doxorubicin, Rats, Wistar, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Thailand Science Research and Innovation, National Science and Technology Development Agency, National Research Council of Thailand.
Abstract (Originalsprache)
An impact of donepezil against doxorubicin-induced gut barrier disruption and gut dysbiosis has never been investigated. Twenty-four male Wistar rats were divided into three groups. Each group was treated with either vehicle as a control, doxorubicin, or doxorubicin-cotreated with donepezil. Heart rate variability was assessed to reflect the impact of doxorubicin and donepezil. Then, animals were euthanized, and the ileum and its contents were collected in each case to investigate the gut barrier and gut microbiota, respectively. The microbiota-derived endotoxin, trimethylamine N-oxide (TMAO), and short-chain fatty acids (SCFAs) in the serum were determined. An increase in the sympathetic tone, endotoxins, and TMAO levels with disruption of the gut barrier and a decrease in SCFAs levels were observed in doxorubicin-treated rats. Gut microbiota of doxorubicin-treated rats was significantly different from that of the control group. Donepezil treatment significantly decreased the sympathetic tone, restored the gut barrier, and reduced endotoxin and TMAO levels in doxorubicin-treated rats. Nonetheless, donepezil administration did not alter the gut microbiota profile and levels of SCFAs in doxorubicin-treated rats. Doxorubicin impaired the autonomic balance and the gut barrier, and induced gut dysbiosis, resulting in gut toxicity. Donepezil partially improved the doxorubicin-induced gut toxicity through balancing the autonomic disturbance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand; Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Ch…
- Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang M…
Förderung
- Thailand Science Research and Innovation
- National Science and Technology Development Agency
- National Research Council of Thailand
- Chiang Mai University
Zitieren
APA
Suparan, K., Sriwichaiin, S., Thonusin, C., Sripetchwandee, J., Khuanjing, T., Maneechote, C., Nawara, W., Arunsak, B., Chattipakorn, N., & Chattipakorn, S. C. (2024). Donepezil ameliorates gut barrier disruption in doxorubicin-treated rats. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2024.114741
Vancouver
Suparan K, Sriwichaiin S, Thonusin C, Sripetchwandee J, Khuanjing T, Maneechote C, et al. Donepezil ameliorates gut barrier disruption in doxorubicin-treated rats. Food and Chemical Toxicology. 2024. doi:10.1016/j.fct.2024.114741
BibTeX
@article{Suparan2024,
author = {Suparan, Kanokphong and Sriwichaiin, Sirawit and Thonusin, Chanisa and Sripetchwandee, Jirapas and Khuanjing, Thawatchai and Maneechote, Chayodom and Nawara, Wichwara and Arunsak, Busarin and Chattipakorn, Nipon and Chattipakorn, Siriporn C},
title = {Donepezil ameliorates gut barrier disruption in doxorubicin-treated rats},
journal = {Food and Chemical Toxicology},
year = {2024},
doi = {10.1016/j.fct.2024.114741}
}
EUVIMED